Summary & Overview
CPT 80081: Obstetric Panel for Prenatal Screening
CPT code 80081 represents a standardized obstetric laboratory panel for prenatal screening and assessment. The panel bundles tests that are critical for maternal and fetal health surveillance—complete blood count with differential, hepatitis B surface antigen, a combined HIV-1 antigen/antibody screen for HIV-1/HIV-2, rubella antibody, qualitative nontreponemal syphilis test, red blood cell antibody screen, and ABO/Rh blood typing. Nationally, this panel is widely used during early prenatal care to identify infectious risks, immune status, hematologic conditions, and blood group compatibility.
Key payers in most coverage landscapes include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of what CPT code 80081 covers clinically and operationally, typical sites of service, and the types of benchmarks and policy details that influence billing and coverage decisions. The publication summarizes payer coverage patterns, common modifier usage, clinical context for ordering the panel, and implications for laboratory workflow and reporting. Data not available in the input for specific payer fee schedules, ICD-10 mappings, and associated taxonomies are noted as unavailable.
Billing Code Overview
CPT code 80081 describes a comprehensive obstetric panel performed by a laboratory analyst. The panel includes a complete blood count with differential, hepatitis B surface antigen test, a single-result HIV-1 antigen/antibody test (screening for HIV-1 and HIV-2), rubella antibody test, a qualitative nontreponemal syphilis test, red blood cell antibody screen, ABO blood typing, and Rh typing.
Service type: Laboratory diagnostic testing panel
Typical site of service: Clinical laboratory or hospital laboratory; specimens are usually collected in outpatient prenatal clinics, obstetrics practices, or inpatient hospital settings.
Clinical & Coding Specifications
Clinical Context
A pregnant patient at an initial prenatal visit has a comprehensive obstetric laboratory panel ordered to establish baseline maternal and fetal risk status. The obstetric panel is performed by the laboratory and includes a complete blood count with differential to assess anemia and infection, hepatitis B surface antigen to detect active hepatitis B infection, a single-result combined antigen/antibody test for HIV-1 and HIV-2 to identify maternal HIV infection, rubella IgG antibody to determine immunity, a qualitative nontreponemal syphilis test (e.g., RPR or VDRL) for syphilis screening, a red blood cell antibody screen to detect clinically significant alloantibodies, and ABO and Rh typing (including Rh(D)) to determine blood group and alloimmunization risk. Typical workflow: physician or midwife documents pregnancy and indications and places electronic lab orders; the patient presents to an outpatient clinic or laboratory phlebotomy unit; a phlebotomist collects specimens with appropriate tubes; the laboratory performs the specified assays, documents results in the electronic medical record, and issues critical value notifications if indicated. Results guide interventions such as hepatitis B vaccination counseling, HIV management and prophylaxis, treatment of syphilis, Rh(D) immune globulin administration planning, and referral to specialty care if infections or significant antibodies are identified.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When billing only the physician/pathologist professional interpretation portion of a test that has a split technical/professional component. |